Optimizing antimicrobial pharmacodynamics: Dosage strategies for meropenemMATTOES, Holly M; KUTI, Joseph L; DRUSANO, George L et al.Clinical therapeutics. 2004, Vol 26, Num 8, pp 1187-1198, issn 0149-2918, 12 p.Article

Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection modelNICOLAU, David P; MATTOES, Holly M; BANEVICIUS, Maryanne et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1630-1635, issn 0066-4804, 6 p.Article

Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh modelTESSIER, Pamela R; MATTOES, Holly M; DANDEKAR, Prachi K et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 1, pp 188-194, issn 0066-4804, 7 p.Article

Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactamKIM, Myo-Kyoung; CAPITANO, Blair; MATTOES, Holly M et al.Pharmacotherapy. 2002, Vol 22, Num 5, pp 569-577, issn 0277-0008Article

Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniaeMATTOES, Holly M; BANEVICIUS, Maryanne; DADONG LI et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 7, pp 2092-2097, issn 0066-4804Article

Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adultsCAPITANO, Blair; MATTOES, Holly M; SHORE, Eric et al.Chest. 2004, Vol 125, Num 3, pp 965-973, issn 0012-3692, 9 p.Article

Comparative pharmacokinetic and pharmacodynamic profile of piperacillin/tazobactam 3.375G Q4h and 4.5G Q6HMATTOES, Holly M; CAPITANO, Blair; KIM, Myo-Kyoung et al.Chemotherapy (Basel). 2002, Vol 48, Num 2, pp 59-63, issn 0009-3157Article